A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)

Andrea Wang-Gillam; Vincent Picozzi; Todd Crocenzi; Michael Morse; Herbert Zeh; Robert Fine; Aimee Murphy; Justin Skoble; Edward Lemmens; Sandy Ferber; Allan Rosen; John Grous; Thomas W Dubensky; Dirk Brockstedt; Elizabeth Jaffee; Dung Le

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)

【24h】

A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)

机译：GVAX胰腺疫苗和CRS-207与化学疗法和CRS-207相比单独在具有先前治疗的转移性胰腺腺癌（Eclipse研究）中的CRS-207（Eclipse研究）相比的疗法，随机多中心研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2014年第s3期|共页
作者
Andrea Wang-Gillam; Vincent Picozzi; Todd Crocenzi; Michael Morse; Herbert Zeh; Robert Fine; Aimee Murphy; Justin Skoble; Edward Lemmens; Sandy Ferber; Allan Rosen; John Grous; Thomas W Dubensky; Dirk Brockstedt; Elizabeth Jaffee; Dung Le;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study) [J] . Le Dung T., Picozzi Vincent J., Ko Andrew H., Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第18期

机译：IIB的结果，随机化，多中心研究GVAX胰腺和CRS-207与具有先前治疗的转移性胰腺腺癌的成人化疗（Eclipse研究）相比
2. Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) [J] . Dung T Le, Todd S Crocenzi, Jennifer N Urum, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：GVAX胰腺（含环磷酰胺）和CRS-207联合或不联合nivolumab在先前治疗过的转移性胰腺腺癌（STELLAR）患者中的安全性，疗效和免疫应答的II期随机研究
3. Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer [J] . Nitya Nair, Ed Lemmens, Amanda Enstrom, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：转移性胰腺癌患者IIa期的长期存活者和免疫生物标记分析，GVAX胰腺和crs-207免疫疗法的随机研究
4. A Phase IIb randomized multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study) [O] . Andrea Wang-Gillam, Vincent Picozzi, Todd Crocenzi, 2014

机译：IIb期随机多中心GVAX胰腺疫苗和CRS-207与先前治疗过的转移性胰腺腺癌的成人相比化学疗法或单独使用CRS-207的疗效比较（日食研究）
5. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study) [O] . 2014

机译：IIb期随机，多中心GVAX胰腺疫苗和CRS-207与先前治疗过的转移性胰腺腺癌的成人相比，化学疗法或单独使用CRS-207的疗效比较（日食研究）

A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)

著录项

相似文献

相关主题

期刊订阅